Surgical articles and methods for treating pelvic conditions

ABSTRACT

Described are pelvic implants and methods of surgically placing pelvic implants, that provide treatment for pelvic floor disorders by support of the levator. A pelvic implant ( 100, 102 ) may comprise a tissue support portion ( 104 ) to be placed in contact with tissue to be supported, extension portions ( 106, 110 ) that extend from the tissue support portion to provide additional support, and tissue fasteners ( 108, 112 ) to attach extension portions to supportive tissue.

PRIORITY CLAIM

This application claims benefit from International Application No.PCT/US2007/016760, having PCT Publication No. WO 2008/013867 A1, whichwas filed on 25 Jul. 2007, which in turn claims priority to U.S.Provisional Application Ser. No. 60/820,306, filed Jul. 25, 2006,entitled “METHOD AND DEVICE FOR SUPPORTING PELVIC FLOOR AND LEVATOR ANIMUSCLES”; U.S. Provisional Application Ser. No. 60/820,564, filed Jul.27, 2006, entitled “METHOD AND DEVICE FOR SUPPORTING PELVIC FLOOR ANDLEVATOR ANI MUSCLES”; U.S. Provisional Application Ser. No. 60/823,858,filed Aug. 29, 2006, entitled “PERINEAL BODY REPAIR WITH TISSUE ANCHORSAND LEVATOR BALLOONING CONCEPTS”; U.S. Provisional Application Ser. No.60/863,049, filed Oct. 26, 2006, entitled “MESH IMPLANTS FOR THETREATMENT OF LEVATOR ANI MUSCLE DEFECTS AND FECAL INCONTINENCE”; andU.S. Provisional Application Ser. No. 60/947,044, filed Jun. 29, 2007,entitled “PELVIC FLOOR TREATMENTS AND ASSOCIATED IMPLANTS”, whichapplications are incorporated herein by reference in their entirety.

FIELD OF THE INVENTION

The invention relates to apparatus and methods for treating pelvicconditions by use of a pelvic implant to support pelvic tissue. Thepelvic conditions include conditions of the female or male anatomy, andspecifically include treatments that involve supporting levator muscle,such as to treat female or male fecal incontinence, among otherconditions.

BACKGROUND

Pelvic health for men and women is a medical area of increasingimportance, at least in part due to an aging population. Examples ofcommon pelvic ailments include incontinence (fecal and urinary) andpelvic tissue prolapse (e.g., female vaginal prolapse). Urinaryincontinence can further be classified as including different types,such as stress urinary incontinence (SUI), urge urinary incontinence,mixed urinary incontinence, among others. Other pelvic floor disordersinclude cystocele, rectocele, enterocele, and prolapse such as anal,uterine and vaginal vault prolapse. A cystocele is a hernia of thebladder, usually into the vagina and introitus. Pelvic disorders such asthese can result from weakness or damage to normal pelvic supportsystems.

Pelvic implants, sometimes referred to as slings, hammocks, have beenintroduced for implantation in the body to treat pelvic conditions suchas prolapse and incontinence conditions. See, for example, commonlyassigned U.S. Pat. Nos. 6,382,214, 6,641,524, 6,652,450, and 6,911,003,and publications and patents cited therein. The implantation of theseimplants involves the use of implantation tools that createtransvaginal, transobturator, supra-pubic, or retro-pubic exposures orpathways. A delivery system for coupling the sling ends to ends ofelongate insertion tools, to draw sling extension portions throughtissue pathways, is also included. Needles of the right and left handinsertion tools described in the above-referenced 2005/0043580 patentpublication have a curvature in a single plane and correspond moregenerally to the BioArc™ SP and SPARC™ single use sling implantationtools sold in a kit with an elongated urethral sling by American.Medical Systems, Inc.

One specific area of pelvic health is trauma of the pelvic floor, e.g.,of the levator (“levator ani”) or coccygeus muscle (collectively thepelvic floor). The pelvic floor is made up of the levator and coccygeusmuscles, and the levator is made up of components that include thepuborectalis muscle, the pubococcygeus muscle, and the iliococcygeousmuscle. For various reasons, the levator may suffer weakness or injurythat can result in various symptoms such as prolapse, incontinence, andother conditions of the pelvis.

SUMMARY

The invention relates to methods of treating pelvic conditions,especially by supporting levator tissue. Levator defects (weakness orinjury) can affect any portion of the levator, and can be especiallycommon in the pubic portion of the levator ani, including thepubococcygeus and puborectalis muscles. Such defects are relativelycommon, for instance, in women with vaginal prolapse. Defects can alsobe present at the iliococcygeus muscle. Still other defects are in theform of a paravaginal defect, such as avulsion of the inferiomedialaspects of the levator ani from the pelvic sidewall; avulsion can referto tissue being detached from the pubic bone, and may precede prolapseconditions. Another levator defect is levator ballooning, which refersto distension of levator muscles.

A different levator defect is a defect of the levator hiatus, which canreduce the stability of the pelvic floor and may result in sexualdysfunction, defecatory dysfunction, rectal prolapse, and fecalincontinence. Levator hiatus is also believed to play a significant rolein the progression of prolapse. Embodiments of methods of the inventioncan address any of the conditions, as well as related conditions andsymptoms.

The present patent application describes pelvic implants and methods fortreating pelvic conditions by treating defects of the pelvic floor(coccygeus or levator), such as weakness or injury, or by otherwisesupporting levator muscle. Useful methods can involve methods andimplants that can restore natural pelvic floor anatomy using an implant(e.g., graft) in the form of a hammock, sling, and the like, to augmentinjured, weakened, or attenuated levator musculature. The levatormusculature or “levator ani” can include the puborectalis,pubococcygeus, iliococcygeus.

Embodiments of implants useful according to the invention can be of asize and shape to address a desired pelvic floor condition, generally ofa size and shape to conform to levator tissue, optionally toadditionally contact or support other tissue of the pelvic region suchas the anal sphincter, rectum, perineal body, etc. The implant can be ofa single or multiple pieces that is or are shaped overall to match aportion of the levator, e.g., that is circular, oblong trapezoidal,rectangular, that contains a combination of straight, angled, andarcuate edges, etc. The implant may include attached or separatesegments that fit together to extend beside or around pelvic featuressuch as the rectum, anus, vagina, and the like, optionally to attach tothe feature.

An implant (e.g., fecal sling) can be a continuous or a non-continuoussling, and can include one or multiple pieces or segments, e.g., anintegral continuous implant or an assembly of segments. A continuousimplant may be substantially continuous between edges, to be placed overa substantially continuous or level surface area of levator tissue. Anon-continuous implant may include breaks or cuts that allow much of theimplant to be placed on a level or continuous surface of levator tissue,with portions being formed to extend around tissue structure extendingfrom or to the levator tissue, such as the anus, rectum, etc.

The implant can include a tissue support portion, which at least in partcontacts levator tissue. Optionally, the implant can additionallyinclude one or more extension portion that extends beyond the tissuesupport portion and to be secured to tissue of the pelvic region, forsupport of the tissue support portion.

Optionally, extension portions can include features such as a tissuefastener (e.g., self-fixating tip, soft tissue anchor, bone anchor,etc.), a sheath, a tensioning mechanism such as a suture, an adjustmentmechanism, etc.

An implant, including a tissue support portion and optionally anextension portion, tissue fastener, etc., may optionally be coated withantimicrobial coatings to prevent infection or coatings to encourageingrowth or inhibit rejection. For tissue support portions and extensionportions, biocompatible materials are contemplated such as porcinedermis or meshes with growth factors.

A method as described herein may improve or treat a condition of thepelvic region, such as any of the pelvic conditions described. Themethod may support levator tissue, for treatment of prolapse; fecalincontinence; a torn, weakened, or damaged levator muscle (meaning anyportion of the levator muscle); levator avulsion, levator ballooning,treatment to support a perineal body; a method of perineal body repair;a method of treating the levator hiatus by tightening or reducing thesize of the levator hiatus; and combinations of one or more of these.The method may also be more general, as a treatment of more generalconditions such as urinary continence, that is believed to be caused byor contributed to by a weakened levator.

The method may be prophylactic or medically necessary. A prophylactictreatment may be a preventative treatment for potential disease orcondition that does not yet exist but that may be likely to exist. Forexample preventative treatment may be useful upon a grade one or twoprolapse, for reinforcement of current prolapse repair, or post-partum.A medically necessary procedure may take place when a disease is presentand in need of immediate treatment, such as in the case of perinealdescent, fecal incontinence, reinforcement of current prolapse repair,and rectal prolapse.

An implant can be placed to contact pelvic tissue as desired, to supportthe tissue, such as levator tissue, and can optionally be secured to thetissue to be supported, e.g., by suturing. The implant can additionallybe secured to tissue of the pelvic region for additional support, suchas to tissue such as: sacrotuberous ligament; sacrospinous ligament;anococcygeal ligament (“anococcygeal body ligament”); periostium of thepubic bone (e.g., in a region of the ischial tuberosity); pubourethralligament; ischial spine (e.g., at a region of the ischial spine);ischial tuberosity; arcus tendineus (used synonymously herein with theterm “white line”), e.g., through a tissue path between levator animuscle and obturator internus muscle and attached at the arcustendineus; obturator internus muscle. Alternately, an extension portionof an implant can be extended through a tissue path that leads to anexternal incision such as: by passing through tissue of the obturatorforamen to pass through an external incision at the inner thigh; passingabove the pubic bone to exit at a suprapubic incision; passing in aposterior direction to an external perirectal or perianal incision,e.g., past the coccyx bone. As another alternative, an implant orextension portion of an implant can be attached to bone or fasciathereof, such as the sacrum or pubic bone, or fascia thereof.

According to exemplary methods, an implant can be introduced through anincision that allows access to levator tissue, optionally with someamount of dissection. The incision can be any of a variety of incisionsthat provide such access, such as a small external perirectal incisionthat can allow a tissue path to extend from the external perirectalincision to levator tissue; an external suprapubic incision; an externalincision at an inner that can be used to pass a portion of an implantthrough an obturator foramen, a Kraske incision under the rectum; anincision at the perineum; and a vaginal incision. An implant or aportion of the implant can be accessed or placed into position using theincision, to support tissue of the levator. Preferably the implant canbe placed by dissecting a plane or region of dissection that includesthe ischorectal fossa. Anatomical landmarks included with this region ofdissection can include the ischial spine, the obturator internus, thearcus tendineus.

One embodiment of implant can be a synthetic or biologic implant havinga tissue support portion. The tissue support portion can be sized andshaped to support levator tissue. The precise form can depend on thetype of condition being treated. Certain embodiments of a tissue supportportion may optionally include a segment or support for addressinglevator hiatus opening, perineal descent, rectal prolapse, fecalincontinence, etc.

An implant may optionally but not necessarily include extension portionsthat extend to other tissue, e.g., in the pelvic region, sometimesreferred to as “supportive tissue,” to which the extension portion maybe secured in a manner to allow the extension portion to support thetissue support portion. Also optionally, ends of extension portions caninclude a tissue fastening mechanism such as a self-fixating tip thatcan be secured to internal tissue of the pelvic region such as describedelsewhere herein, including but not limited to tissue of: sacrotuberousligament, sacrospinous ligament, periostium of the pubic bone (e.g., ina region of the ischial tuberosity), a region of the ischial spine,ischial tuberosity, pubourethral ligament, anococcygeal body ligament,and arcus tendineus; or through a tissue path between levator ani muscleand obturator internus muscle and attaching the extension portion at thearcus tendineus or obturator tissue (e.g., obturator internus), orpassing through tissue of the obturator foramen.

The invention contemplates various methods of supporting levator tissue.Exemplary methods include steps that involve creating a single medialincision (a transvaginal incision or a perineal incision) or an incisionnear the rectum, anus, or perineum; and dissecting within a plane orregion of dissection including the ischorectal fossa. An implant can beinserted to contact tissue of the levator, over a desired area.Optionally, the implant can be a single piece or multiple pieces orportions, and may include one or more tissue fasteners that can besecured to tissue in the pelvic region. An implant may include materialsor components such as those used in the SPARC and Monarc systems (fromAmerican Medical Systems), include connectors for engagement between aneedle of an insertion tool and an distal end of an extension portion,as well as helical, straight, and curved needles.

The invention furthermore contemplates embodiments of methods andapparatus for treating pelvic conditions that involve a single incisionwhereby the implant does not exit through another skin incision such asan abdominal or leg incision.

In one aspect, the invention relates to a method of supporting tissue ofthe pelvic floor, include levator tissue, coccygeus tissue, andcombinations of these. The method includes: creating an incision thatallows access to a region of inferior tissue of the pelvic floor,providing a pelvic implant comprising a tissue support portion, passingthe implant through the incision and placing the tissue support portionat the region of the inferior tissue of the pelvic floor, andpositioning the tissue support portion at the region of the inferiortissue in a manner to cause the tissue support portion to support thelevator tissue.

In another aspect, the invention relates to pelvic implant forsupporting tissue of the pelvic floor (e.g., levator tissue, coccygeustissue, or combinations of these), and related surgical systems andkits. The implant includes a tissue support portion bounded by: ananterior side capable of extending from an anterior region of the pelvicregion to a region of tissue of the medial pelvic floor, the anteriorregion selected from a region of the obturator foramen, a region of thearcus tendineus, and a region of puborectalis muscle; a posterior sidecapable of extending from a posterior region of the pelvic region to aregion of the medial pelvic floor, the posterior region selected from aregion of the ischial spine, an ischial tuberosity, a sacrospinousligament, a sacrotuberous ligament, and a sacrum, and a lateral endcapable of extending from the anterior region to the posterior region.The tissue support portion can be located at a region of levator tissue.

In another aspect the invention relates to a method of treating a pelviccondition by supporting tissue of the pelvic floor. The method includes:providing an implant comprising a tissue support portion and a tissuefastener, creating an incision that allows access to tissue of thepelvic floor, placing the tissue support portion in contact with tissueof the pelvic floor, and securing the tissue fastener to tissue of thepelvic region.

BRIEF DESCRIPTION OF DRAWINGS

Other features and advantages of the present invention will be seen asthe following description of particular embodiments progresses inconjunction with the drawings. Drawings are schematic and not to scale.

FIG. 1 illustrates an embodiment of an implant as described.

FIG. 2 illustrates an embodiment of an implant as described.

FIG. 3 illustrates an embodiment of an implant as described.

FIG. 4 illustrates an embodiment of an implant as described.

FIG. 5 illustrates an embodiment of a kit comprising an implant asdescribed and an insertion tool.

FIG. 5A illustrates an embodiment of a kit comprising an implant asdescribed and an insertion tool.

FIG. 6 illustrates anatomy of the pelvic region.

FIG. 7 illustrates an embodiment of tissue path as described.

FIGS. 8, 8A, 8B, and 8C, illustrate embodiments of incisions asdescribed.

FIG. 8A illustrates an embodiment of incision as described.

DETAILED DESCRIPTION

The following description is meant to be illustrative only and notlimiting. Other embodiments of this invention will be apparent to thoseof ordinary skill in the art in view of this description.

The invention relates to surgical instruments, assemblies, andimplantable articles for treating pelvic floor disorders such asprolapse, incontinence (urinary and fecal incontinence), conditions ofthe perineal body, conditions of levator muscle (such as a component oflevator muscle), conditions of the levator hiatus, and combinations oftwo or more of these. According to various embodiments, a surgicalimplant can be used to treat a pelvic condition, wherein the methodincludes placing an implant in a manner that support tissue of thepelvic floor, including one or more of levator muscle and coccygeusmuscle, in males or females. Various aspects of the invention aredescribed as embodied by features of surgical implants, surgical tools,surgical systems, surgical kits, and surgical methods, useful forimplants and for installing implants.

Defects of the pelvic floor, such as levator muscle distension orballooning, may have a significant effect on perineal body descent andacute, potential, impending, or future pelvic prolapse, as well asprolapse recurrence. One embodiment of the invention involves methods bywhich tissue of the pelvic floor (e.g., levator muscle, coccygeusmuscle) can be supported to reduce this distension. This embodimentinvolves placing various materials subcutaneously against levator orcoccygeus muscle; the placement can be made by any incision anddissection route, but particular methods involve incisions in theperirectal, perianal, and perineal regions and not necessarily by use ofa transvaginal incision. (According to other embodiments, an implant canbe placed tranvaginally.)

According to certain embodiments of the invention, tissue of the pelvicfloor can be supported by an implant in the form of a mesh or biologicsling, hammock, or the like, similar to some of those that have beenused previously to treat pelvic conditions such as forms of urinaryincontinence, prolapse, fecal incontinence, etc., in men and women.

Other possible support mechanisms can be useful as well, other thanthose similar to such conventional pelvic implants, which may beconsidered “static.” Examples of other support structures (i.e.,“implants”) include structures that are dynamic and not static. Adynamic implant can exhibit the ability to change after being implantedin a manner that can allow a dynamic function, such as dynamic support.The degree of support may be changed or adjusted at different stages ofa disease or condition.

Examples of alternate support mechanisms (static or non-static) includebut are not limited to: bulking agents (collagen, saline, silicone,etc.), expandable foam/insulation to fill volume, pillows filled withsaline, silicone, or the like, that could be deflated and inflated toaid in defecation, sponges that could be combined with growth factors tofacilitate ingrowth or used along to fill space.

Embodiments of methods that do not include vaginal dissection may beeasier to perform and reduce risk and tissue trauma to the patient. Thisrepair may be done during or after performing other treatments of thepelvic floor, such as to treat vaginal prolapse (e.g., vault prolapse,enterocele, rectocele, cystocele, etc.), may reduce the recurrence rateof vaginal prolapse (e.g., as addressed by products such as the Apogee™and Perigee™ prolapse products from American Medical Systems, andsimilar products), and may provide an overall improvement when used incombination with or after other prolapse repair procedures. Alternately,procedures of the invention may be used prophylactically to preventfuture prolapse. The procedures may be performed before, after, orconcurrently with a hysterectomy, to potentially prevent or reduce thepossibility or severity of subsequent prolapse. In other embodiments, amethod as described may be useful following a prostatectomy or bladderremoval (due to cancer), again to potentially prevent or reduce thepossibility or severity of subsequent pelvic conditions.

Aspects of the invention relate to the use of an implant (e.g.,polypropylene mesh), surgically implanted to support the levator musclesto reduce levator muscle distension, or to otherwise repair levatortissue. Techniques can involve delivering an implant (e.g., a mesh) totissue of the levator and securing it into place to support the levatortissue. These procedures and devices involve placing an implantsubcutaneously against the levator muscle (i.e., below or inferior tothe levator muscle). This can be done transvaginally, but also can bedone with an external incision in the perineal area (of the male orfemale anatomy), perirectal area, or with other incision locations.

In certain embodiments, the implant (either the tissue support portionor an extension portion) can also be secured to other tissue, i.e.,“supportive tissue,” of the pelvic region, to support the tissue supportportion. Exemplary supportive tissue is described herein, for example atFIG. 6 and related text, and is described at other portions of thepresent description. Supportive tissue includes, tissue at an anteriorlocation such as at the obturator foramen or arcus tendineus, or at aposterior location such as a region of the ischial spine or at asacrospinous ligament.

The implant can be attached to such supportive tissue directly or by useof a tissue fasteners (e.g., anchors such as bone anchors, soft tissueanchors, self-fixating tips, tissue clamps, etc.) A tissue fastener maybe attached to a tissue support portion or to an extension portion of animplant, and may be attached to either of these directly or by aconnective suture. According to the latter, a tissue fastener can beplaced and then material of the implant (e.g., mesh) may be guided alongthe suture lines as a track or guide to be tacked into place.

Embodiments of certain implants can be of materials and designs thatwill be the same as or similar to implants conventionally useful forother treatments of the pelvic region. An implant can include a tissuesupport portion (or “support portion”) that can be used to supportpelvic tissue, especially tissue of levator muscle. During use, thetissue support portion is typically placed in contact with tissue to besupported, e.g., levator tissue, and optionally in addition, tosurrounding tissue such as tissue of the rectum, tissue of a perinealbody, tissue of the external anal sphincter, to support one or more ofthese. Also optionally the tissue support portion can be attached tosuch tissue, for example as with a suture, biological adhesive, etc.

Embodiments of implants can optionally include one or more extensionportions (also sometimes referred to as “end portions” or “arms”)attached to the tissue support portion. Extension portions are pieces ofmaterial, for example elongate pieces of material, that extend from thetissue support portion and either are or can be connected to the tissuesupport portion, and are useful to attach to or pass through anatomicalfeatures in the pelvic region to provide support for the tissue supportportion and the supported tissue. One or multiple (e.g., one, two, orfour) extension portions can extend from the tissue support portion aselongate “ends,” “arms,” or “extensions,” useful to attach to tissue inthe pelvic region, such as by extending through a tissue path to aninternal anchoring point as described herein. Optionally, according toalternate embodiments of the invention, the extension portion may passthrough tissue of the pelvic region and to an external incision.

Embodiments of exemplary implants that may be useful as discussed hereincan include a tissue support portion and no extension portions. Otherembodiments can include one, two, three, or more extension portionsattached to a tissue support portion. An exemplary urethral sling can bean integral mesh strip or hammock with supportive portions consisting ofor consisting essentially of a central support portion and zero, one, ortwo extension portions.

An implant may include portions or sections that are synthetic or ofbiological material (e.g., porcine, cadaveric, etc.), and that may beresorbable or non-resorbable. Extension portions may be, e.g., asynthetic mesh such as a polypropylene mesh. The tissue support portionmay be synthetic (e.g., a polypropylene mesh) or biologic.

The implant, either or both of the tissue support portion or anextension portion, may comprise variable weave meshes with varyingelasticities such as a mesh that is highly elastic around the anus toallow stool to pass.

Some example of commercially available materials may include MarleX™(polypropylene) available from Bard of Covington, R.I., Prolene™(polypropylene) and Mersilene (polyethylene terephthalate) Hernia Meshavailable from Ethicon, of New Jersey, Gore-TeX™ (expandedpolytetrafluoroethylene) available from W. L. Gore and associates,Phoenix, Ariz., and the polypropylene sling material available in theSPARC™ sling system, available from American Medical Systems, Inc. ofMinnetonka, Minn. Commercial examples of absorbable materials includeDexon™ (polyglycolic acid) available from Davis and Geck of Danbury,Conn., and Vicryl™ available from Ethicon.

Dimensions of an implant can be as desired and useful for any particularinstallation procedure, treatment, patient anatomy, to support aspecific tissue or type of tissue, and to extend to a desired locationof internal supportive tissue or an external incision. Exemplarydimensions can be sufficient to allow the tissue support portion tocontact tissue of the levator, coccygeus, rectum, external analsphincter, etc., or any desired portion of one or more of these.Optionally, one or more extension portion can extend from the tissuesupport portion to a desired internal or external anatomical location toallow the extension portion to be secured to anatomy of the pelvicregion, to support the tissue support portion.

Dimensions of extension portions according to the invention can allowthe extension portion to reach between a tissue support portion placedto support tissue of the pelvic floor (at an end of the extensionportion connected to the tissue support portion) and a location at whichthe distal end of the extension portion attaches to pelvic tissue, ormay optionally pass through an external incision.

An implant can be of a single or multiple pieces that is or are shapedoverall to match a portion of the levator, e.g., that is completely orpartially circular, trapezoidal (non-symmetric or symmetric),rectangular, rhomboidal, etc. The implant may be multiple pieces to fitbeside or around pelvic features such as the rectum or anus.Alternately, the implant may be irregular (while optionally symmetrical)to reach different areas of the levator.

To contact tissue of the pelvic floor, an implant (e.g., fecal sling)can be a continuous or a non-continuous sling, and of one or multiplepieces or segments. A continuous implant may be substantially continuousbetween edges, to be placed over a level surface area of levator tissue.A non-continuous implant may include breaks or cuts that allow much ofthe implant to be placed on a level surface of levator tissue, withportions being formed to extend around tissue structure extending fromor to the levator tissues, such as the anus, rectum, etc.

An embodiment of a non-continuous sling may be designed to cover orcontact area of the levator, coccygeus, or both, and also reach aroundto contact a posterior side of the rectum or external anal sphincter.For example, a portion of an implant could attach to the lateral sidesof the external anal sphincter and extend toward or in the direction ofthe obturator foramen, or any other suspensory structure (e.g.,supportive tissue), but need not engage tissue of the obturator foramendirectly. In this embodiment, the tissue support portion of the implantneed not necessarily be directly under the anus to provide thecorrective action for fecal incontinence. An advantage to of thisapproach is to allow the anus to expand unrestricted to facilitatenormal rectal function and may give the levator plate (or plates) thesupport necessary to be leveraged.

Embodiments of implants can include a segment that is located anteriorto the anus, such as in contact with levator tissue or tissue of theperineal body, anterior to the anus. Alternate implants may be designedto replace the perineal muscle or attach to the superior portion of theexternal sphincter. The various embodiments disclosed herein are alsoapplicable to men and can be implanted via an incision in the perinealfloor (see attached figures).

An implant, e.g., at a tissue support portion or at a distal end of anextension portion, can optionally include a tissue fastener thatattaches to tissue of the pelvic region. The tissue fastener can be,e.g., a soft tissue anchor, a self-fixating tip, a biologic adhesive, atissue clamp, opposing male and female connector elements that securelyengage when pushed together, or any other device to secure a distal endof an extension portion to tissue of the pelvic region. Exemplary tissuefasteners are discussed, e.g., in PCT/SU2007/014120 “Surgical Implants,Tools, and Methods for Treating Pelvic Conditions, filed Jun. 15, 2007;the entirety of which is incorporated herein by reference. The implantmay also have extension portions that do not include a tissue fastenerat a distal end thereof, for example if the distal end is designed to besecured to tissue by other methods (e.g., suturing), or is intended topass through a tissue path ending in an external incision.

An extension portion can be attached to any desired tissue of the pelvicregion, or passed through a desired tissue path to an external incision.To attach an extension portion to tissue, a tissue fastener canoptionally be attached at the distal end of the extension portion.During installation of the implant, the tissue fastener can be attachedto any desired tissue, e.g., supportive tissue, many examples of whichare described herein. Supportive tissue can be fibrous tissue such as amuscle (e.g., obturator foramen, especially the obturator internus;obturator externus; ligament such as the sacrotuberous ligament,sacrospinous ligament, or surrounding tissue; a tendon such as the arcustendineus or surrounding tissue; or tissue at or near the ischial spine(i.e., at a region of the ischial spine) such as the ischial tuberosity.

A length of an extension portion (extended through any tissue path) canoptionally be fixed or adjustable, allowing a surgeon to alter thelength of an extension portion before, during, or after implantation. Onthe other hand, adjustment and tensioning mechanisms can also beexcluded from embodiments of implants or from particular extensionportions, e.g., superior extension portions that will attach to anobturator foramen, or extension portions that will be placed at a tissuepath extending to an external incision.

A length of an extension portion can be sufficient to allow the distalend to reach desired tissue within or external to the pelvic region,e.g., from about 1 centimeter (cm) to about 5 centimeters. A width ofthe extension portion can be as desired, such as within the range fromabout 1 to 1.5 centimeters.

A “self-fixating tip” in general can be a structure connected to adistal end of an extension portion that can be implanted into tissue ina manner that will maintain the position of the self-fixating tip andsupport the attached implant. Exemplary self-fixating tips can also bedesigned to engage an end of an insertion tool (e.g., elongate needle,elongate tube, etc.) so the insertion tool can be used to push theself-fixating tip through tissue for implantation. The self-fixating tipmay engage the insertion tool at an internal channel of theself-fixating tip, at an external location such as at a cylindricalbase, or at a lateral extension, as desired. Exemplary self-fixatingtips are described, for example, in PCT/US2007/004015 “Surgical Articlesand Methods for Treating Pelvic Conditions,” filed Feb. 16, 2007, theentirety of which is incorporated herein by reference.

A self-fixating tip can be made out of any useful material, generallyincluding materials that can be molded or formed to a desired structureand connected to or attached to an end of an extension portion of animplant. Useful materials can include plastics such as polyethylene,polypropylene, and other thermoplastic or thermoformable materials, aswell as metals, ceramics, and other types of biocompatible andoptionally bioabsorbable or bioresorbable materials. Exemplarybioabsorbable materials include, e.g., polyglycolic acid (PGA),polylactide (PLA), copolymers of PGA and PLA.

A self-fixating tip may be of any form that can be inserted into tissueof a pelvic region, and that will thereafter be retained in the tissue.Exemplary self-fixating tips can include one or more lateral extensionsthat can increase the force required to remove the self-fixating tipfrom tissue after insertion into the tissue, i.e. the “pullout force.”At the same time, the lateral extensions can be designed to exhibit areduced or relatively low “insertion force,” which is the amount offorce used to insert the self-fixating tip into tissue. Theself-fixating tip can be designed to be essentially permanently placedupon insertion into tissue, with the single exception that if absolutelynecessary to provide desired placement of the self-fixating tip or anattached implant, the self-fixating tip may be removed by a surgeonduring an implantation procedure. The self-fixating tip, and allcomponents of the self-fixating tip, can be of combined form anddimensions to result in these functional features.

According to exemplary embodiments, a self-fixating tip can havestructure that includes a base having a proximal base end and a distalbase end. The proximal base end can be connected (directly orindirectly, such as by a connective suture) to a distal end of anextension portion, or directly to a tissue support portion of animplant. The base extends from a proximal base end to a distal base endand can optionally include an internal channel extending from theproximal base end at least partially along a length of the base towardthe distal base end. The optional internal channel can be designed tointeract with (i.e., engage) a distal end of an insertion tool to allowthe insertion tool to be used to place the self-fixating tip at alocation within pelvic tissue of the patient.

Alternate embodiments of self-fixating tips do not require and canexclude an internal channel for engaging an insertion tool. Thesealternate embodiments may be solid, with no internal channel, and mayengage an insertion tool, if desired, by any alternate form ofengagement, such as, for example, by use of an insertion tool thatcontacts the self-fixating tip at an external location such as bygrasping the base (on a side or at the face of the proximal base end) orby contacting a lateral extension.

Embodiments of self-fixating tips also include one or more lateralextension extending laterally (e.g., radially) from the base, such asfrom a location between the proximal end and the distal end, from alocation at the distal base end, or from a location at the proximal baseend.

A self-fixating tip can be connected to an implant, such as at anextension portion of an implant, or to a tissue support portion, in anyfashion, directly by any attachment mechanism, or indirectly such asthrough an attachment structure such as a suture. A connection can bebased on a mechanical structure, by adhesive, by a connecting suture, orby an integral connection such as by injection molding or “insert”molding (also, “overmolding”) as described U.S. Publication No.2006-0260618-A1, incorporated herein by reference. According to thatdescription a thermoplastic or thermosetting polymer material can beinsert molded or injection molded at an end of a mesh extension portionof an implant, e.g., directly to the mesh. By this method, a moldedpolymer can form a self-fixating tip at an end of an extension portion.The self-fixating tip can be as described herein, for example, includinglateral extensions and an internal channel.

An example of an implant is shown at FIG. 1. Implant 2, including tissuesupport portion 10, is generally in the form of a symmetric trapezoid(with added extension portions 12), but may alternately be a symmetricrectangle, a rhombus, a square, a non-symmetric trapezoid, an oblongrectangle, or the like. Two extension portions 12 are located at cornersthat connect wide end 4 to sides 6. Sides 6 extend and terminate atnarrow end 8. Tissue fasteners (not shown) can be placed at extensionportions 12. In use, an extension portion can be attached to tissue ofthe pelvic region; for example one of tissue extension portions 12 canbe attached to tissue in a posterior location such as a region of theischial spine, sacrospinous ligament, ischiorectal fossa, oriliococcygeous muscle; the other extension portion can be attached at ananterior location such as at tissue of the obturator foramen, e.g., theobturator internus muscle near the inferior pubic ramus, tissue of thearcus tendineus, etc. This places long end 4 at a lateral position.Tissue support portion 10 extends medially below levator tissue andshort end 8 becomes located at a medial position. Short end 8 can beplaced, for example, under the rectum. When so placed the implantextends from lateral positions between a region of the ischial spine orsacrospinous ligament, to a region of the obturator foramen or arcustendineus, with tissue support portion 10 in contact with levatortissue, and with short end 8 at a medial position, e.g., near therectum, optionally under the anococcygeal body ligament.

Lengths of the ends and sides can be as desired to allow for thisplacement. For example, length L1 can be in the range from 6 to 12centimeters, such as from 7 to 10 centimeters. Length L2 of wide end 4(not including extension portions 12) can be, e.g., from 3 to 5centimeters. Length L3 of narrow end 8 can be, e.g., from 2 to 3centimeters.

According to methods of the invention, implant 2 can be inserted througha medial incision, such as at the perineum, and placed as described,below levator tissue. Implant 2 is placed on one side of the pelvicfloor to support substantially one side or half of levator muscle. Asecond implant of the same design can be placed to support thecontralateral side, according to the same method. In this embodiment ofimplant and method, two separate implants are used, one below each sideof the levator muscle, with short ends extending to a medial location.Preferably, the implants are also located below the superficialtransverse perineal muscle. The short ends may overlap or be secured toeach other or to tissue of the pelvic region, e.g., by a suture or othersecuring means such as adhesive, staples, etc.

In FIG. 1, implant 12 can be a synthetic or a biologic material. FIG. 2shows an example of an implant, 20, of synthetic mesh. Self-fixatingtips 22 are located at corners of the implant (either with or in theabsence of an extension portion). Again, implant 20 is designed formethods that use two opposing implants, one to support each side of thelevator muscle.

FIG. 3 illustrates an alternate implant, implant 30, which includes twoopposing trapezoidally shaped portions of an implant, the opposingportions being connected integrally at the middle by a connection ofnarrow ends. Implant 30 may be integrally constructed or prepared fromtwo implants of the type shown in FIG. 2. Implant 30 also includesself-fixating tips 32, which, in use, can be placed as described forextension portions 12 of implant 2. In use, narrow medial portion 34 ofimplant 30 can be placed medially, e.g., under the rectum. Lengths ofwide ends 36 can be, e.g., from 4 to 5 centimeters. The width of implant30 at narrow medial portion 34 can be, e.g., from 2 to 3 centimeters.The total length (the direction perpendicular to with at medial portion34) can be, e.g., from 14 to 18 centimeters, e.g., from 15 to 17centimeters.

Another embodiment of an implant is shown at FIG. 4. Implant 40,including tissue support portion 54, is generally in the form of anon-symmetric trapezoid. Two extension portions, anterior extensionportion 44 and posterior extension portion 42, are located at cornersthat connect lateral end 52 to anterior side 46 and posterior side 50.Anterior side 46 and posterior side 50 extend medially to medial end 48.Tissue fasteners (not shown) can optionally be placed at extensionportions 42 and 44. In use, anterior extension portion 44 can beattached to tissue of the anterior pelvic region, for example tissue ofthe obturator foramen, e.g., the obturator internus muscle near theinferior pubic ramus, or at tissue of the arcus tendineus. Posteriorextension portion 42 can be attached to tissue of the posterior pelvicregion, such as in a region of the ischial spine, e.g., at asacrospinous ligament, ischiorectal fossa, or iliococcygeous muscle.Lateral side 52 extends anteriorly to posteriorly at a lateral position,and medial end 48 becomes located at a medial position, for example,under the rectum. When so placed the implant extends from lateralpositions between, e.g., a region of the ischial spine, and, e.g., aregion of the obturator foramen, with tissue support portion 54 incontact with levator tissue, and with medial end 48 at a medialposition, e.g., near the rectum, optionally under the anococcygeal bodyligament. Overall, the implant can provide lateral support along theiliococcygeus muscle, and more central support along the pubococcygeusand puborectalis.

Lengths of the ends and sides can be as desired to allow for thisplacement. For example, a lateral end 52 can be, e.g., from 5 to 7centimeters. A length of anterior side 46 can be can be in the rangefrom 5 to 10 centimeters, such as from 6 to 9 centimeters. A length ofposterior side 50 can be somewhat shorter, such as from 4 to 8centimeters, or from 5 to 6 centimeters. Length of medial end 48 can be,e.g., from 2 to 3 centimeters.

In FIG. 4, implant 40 is of synthetic mesh, but can alternately be of abiologic material.

According to methods of the invention, implant 40 can be insertedthrough a medial incision (e.g., a perineal incision) and placed asdescribed, below tissue of the pelvic floor such as coccygeus muscle orlevator muscle. Implant 40 is placed below tissue of one side of thepelvic floor, to support substantially one side or half of the pelvicfloor. A second implant of the same design (but in the form of a mirrorimage) can be placed to support the contralateral side of the pelvicfloor, according to the same method. In this embodiment of implant andmethods, two separate implants are used, one to support each side of thelevator muscle, with medial ends extending to a medial location.Preferably, the implants are also located below the superficialtransverse perineal muscle. The medial ends may overlap or be secured,e.g., by a suture or other securing means such as adhesive, staples,etc. In an alternate embodiment, two implants, 40, and a mirror image,can be connected at medial ends and used as a single implant.

An insertion tool can be used to install an implant. Various types ofinsertion tools are known, and these types of tools and modificationsthereof can be used according to this description to install an implant.Examples of useful tools include those types of tools that generallyincludes a thin elongate needle that attaches to a handle; a handleattached to one end (a proximal end) of the needle; and a distal end ofthe needle adapted to engage a self-fixating tip that allows the needleto push the self-fixating tip through a tissue passage and insert theself-fixating tip within tissue of the pelvic region. (In alternateembodiments, a connector can be used in place of the self-fixating tip,the connector being able to engage a distal end of an insertion tool toallow the connector to be pushed or pulled through a tissue path leadingto an external tissue incision.) This class of tool can be used with aself-fixating tip (or other form of connector) that includes an internalchannel designed to be engaged by a distal end of an insertion tool.

Other general types of insertion tools will also be useful, but mayengage a self-fixating tip (or connector) in a manner that does notinvolve an internal channel of a self-fixating tip. These alternateinsertion tools may for example contact or grasp a proximal base end ofa self-fixating tip in the absence of an internal channel extending fromthe proximal base end toward the distal base end, such as by grasping anexternal surface of the base. An alternate insertion tool may contact orgrasp a side of the base, a lateral extension, or any other portion ofthe self-fixating tip or base, in a way that allows the insertion toolto hold the self-fixating tip and insert the self-fixating tip at adesired location within tissue of the pelvic region.

Exemplary insertion tools for treatment of incontinence and vaginalprolapse are described, e.g., in U.S. patent application Ser. Nos.10/834,943, 10/306,179; 11/347,553; 11/398,368; 10/840,646; PCTapplication number 2006/028828; and PCT application number 2006/0260618;among others. Tools described in those patent documents are designed forplacement of an implant in a pelvic region for the treatment ofprolapse, male or female incontinence, etc. The tools of theabove-referenced patent documents may be straight or may be curved intwo or three dimensions, and may include, for example, a helical portionin three dimensions for placing an extension portion of an implantthrough a tissue path that passes from a region of the urethra, throughan obturator foramen, to an external incision in the groin or innerthigh area. Other described insertion tools include a two orthree-dimensional elongate needle that allows a user to place anextension portion of an implant through an external incision, e.g., at asuprapubic location or at a perianal or perirectal location.

Exemplary insertion tools for use according to the invention can besimilar to or can include features of tools described in theabove-referenced patent documents. For use according to embodiments ofmethods described herein, wherein an implant includes a self-fixatingtip, those insertion tools may be modified to allow the insertion toolto be used to place a self-fixating tip at tissue within the pelvicregion through a tissue path that does not extend to an externalincision. The insertion tool can be designed, shaped, and sized, toinclude an elongate inserter or needle that may be straight or that maybe curved in two or three dimensions, that can be inserted through avaginal incision (for female anatomy), through a perineal incision (formale anatomy), or through any one of the other incisions describedherein, and to extend from that incision to a pelvic tissue location forplacement of a self-fixating tip.

Certain embodiments of insertion tools can be designed to reach througha vaginal incision, perineal incision, or other described incision,through an internal tissue path and to then extend through a secondexternal incision, e.g., at the inner groin, thigh, abdominal area,suprapubic region, or perirectal or perianal region. Alternate tools canbe sized and shaped to place a self-fixating tip at an internal locationof the pelvic region, and do not need to be sufficiently long to extendfrom an incision to an external incision. The length can be onlysufficient to reach from a vaginal or perirectal incision to anobturator foramen, region of the ischial spine, sacrospinous ligament,or other location of placing a self-fixating tip. Alternately, thelength may be only sufficient to reach from a desired incision to adifferent muscle or tissue, such as a levator ani, coccygeous muscle,iliococcygeous muscle, arcus tendineus, etc., to place a self-fixatingtip at one of those tissues.

According to an aspect of the invention, an implant can include one ormultiple self-fixating tips at a tissue support portion or optionally atone or multiple ends of optional extension portions, and an implantationmethod can include placing the self-fixating tip or tips within tissuein the pelvic region to support the implant as the implant supports atype of pelvic tissue. The tissue can be a fibrous tissue such as amuscle (e.g., of the obturator foramen, obturator internus, obturatorexternus, levator ani, coccygeous, iliococcygeous), ligament (e.g.,sacrospinous ligament), tendon (arcus tendineus), etc. Also preferably,but not as a requirement of the invention, a self-fixating tip can beoriented in a fibrous tissue to cause a major dimension (referred toherein as the “width”) of a lateral extension to be oriented in adirection that is not parallel to the direction of the fibers.

To control the placement and degree of support of the implant relativeto a tissue to be supported by the implant, the self-fixating tip can beinserted at a desired point of entry relative to the total area of thetissue, and, for tissues of sufficient thickness or depth, theself-fixating tip can be inserted to a selected depth.

A single example of a method according to the invention is a method ofimproving positioning of, or supporting, tissue of the pelvic floor or aportion thereof, by surgical implantation of an implant (e.g., a single,integral, optionally uniform, woven polymeric mesh strip) through anincision that allows access to the tissue of the pelvic floor (e.g.,levator tissue, coccygeus tissue), such as a vaginal incision (forfemale anatomy), perineal (for male or female anatomy) incision, oranother incision as described herein. Certain embodiments of thesemethods can advantageously involve only a single incision (a vaginalincision in a female or a perineal incision in a female or male) and canexclude the need for any additional incision.

An embodiment of a kit according to the invention, including aninsertion tool and an implant, is shown at FIG. 5. Implant 100 can beinstalled to support tissue of the levator. Implant 100 is designed tosupport a portion of levator tissue, and implant 102 is designed tosupport a contralateral portion of levator tissue. Each implant includesa tissue support portion (104), an anterior extension portion (106) thatincludes a tissue fastener (108) in the form of a self-fixating tip.Each implant also includes a posterior extension portion (110) thatincludes a tissue fastener (112) in the form of a self-fixating tip.Sides and ends include: lateral ends 136, which can extend along alateral portion of the levator, such as near the arcus tendineus betweenan anterior position and a posterior position; anterior sides 132extending from medial end 130 to anterior extension portion 106;posterior sides 134 extending from medial end 130 to posterior extensionportion 110; and medial end 130.

Tool 120 is also part of the kit. Tool 120 includes handle 122 connectedto a proximal end of elongate needle 124. Distal end 126 is configuredto engage internal channels or bores 128 (shown in dashed lines) of eachof the tissue fasteners 108 and 112. Tool 120 is shown to have astraight needle portion 124, but could have a needle portion that iscurved in two or three-dimensions.

FIG. 5 shows two implants, 102 and 100, which are mirror images of eachother in the form of non-symmetric trapezoids, as part of a kit.Alternate kits could include two implants of other shapes, e.g., asdiscussed herein, including a rectangle, symmetric trapezoid, square, orany of these general shapes, alternately with one or more of thestraight edges being arcuate if desired. In other alternate kits, animplant can be in the form generally of the two implants connected(e.g., integrally or by a connection mechanism such as a suture) atmedial ends 130. (See FIG. 5A.)

Optionally, according to various implant embodiments, such as implant100 or 102, a material that forms any portion of a sling 100 may includeone or more substances incorporated into the material or coated onto thematerial of the sling. Examples of substances may include, withoutlimitation, drugs, hormones, antibiotics, antimicrobial substances,dyes, silicone elastomers, polyurethanes, radiopaque filaments orsubstances, position or length indicators, anti-bacterial substances,chemicals or agents, including any combinations thereof. A substance ormaterial may be used to enhance treatment effects, reduce potentialsling rejection by the body, reduce the chances of tissue erosion, allowor enhance visualization or location monitoring, indicate proper slingorientation, resist infection, or other provide other desired, useful,or advantageous effects.

Also with respect to any implant, such as implants 100, 102, oralternate embodiments, sling tension may be adjusted by a tension membersuch as a tensioning suture disclosed, for example, in U.S. Pat. No.6,652,450. The tensioning suture may be constructed from a permanent orabsorbable (i.e., bioresorbable or bioabsorbable) material. Thetensioning member may be located along any portion of the implant suchas a tissue support portion or extension portion.

Certain embodiments of the present invention are described withreference to supporting levator tissue and coccygeus tissue.Additionally, the invention is also useful for more specificallytreating symptoms caused by weakened or damaged levator or coccygeustissue, in both males and females. For example, embodiments of thepresent invention would be suitable for a variety of pelvic floorrepairs or treatments, including pelvic organ prolapse repair, levatorballooning, a paravaginal defect such as levator avulsion, levatorhiatus repair, fecal incontinence treatment, perineal body support,rectal support, levator tissue repair, etc.

FIG. 6 shows anatomy relevant to methods and devices of embodiments ofthe invention. Referring to FIG. 6, illustrated is an view of inferiortissue at different levels of the pelvic region, including gluteusmaximus 200, levator ani 202 (which includes the iliococcygeus muscle),sacrotuberous ligament 204, ischial tuberosity 206, superficialtransverse perineal muscle 208, pubococcygeus muscle 210, puborectalismuscle 212, and perineal body 214. Epidermis 218 and coccyx 216 areshown for reference.

According to exemplary methods of the invention, a method of supportinglevator or coccygeus tissue can include a step of creating an incisionthat allows access to a region of lower (inferior) levator or coccygeustissue. Upon making the incision, some amount of dissection may bepreferred or necessary. For example, placement of an implant may beperformed with dissection of a plane or region of dissection thatincludes the ischorectal fossa. Anatomical landmarks included with thisregion of dissection can include the ischial spine, the obturatorinternus, the arcus tendineus.

An implant or a portion of an implant can be inserted through theincision or accessed through the incision. The implant can be asgenerally or specifically described herein, such as in any of FIGS. 1through 4, 5, and 5A, including a tissue support portion, and optionallyincluding one or multiple tissue fasteners optionally located at acorner of an implant or at a distal end of an optional extensionportion. The implant can be passed through the incision and the tissuesupport portion is placed to support levator tissue, coccygeus tissue,or both, at an inferior region or inferior side thereof (i.e., “below”or inferior to tissue).

According to certain embodiments of the invention, the tissue supportportion can also be located below (inferior to) the superficialtransverse perineal muscle, to support this tissue as well. The tissuesupport portion can optionally be secured to levator tissue, tissue ofthe superficial transverse perineal muscle, or both. The tissue supportportion is positioned at a region of inferior levator tissue in a mannerto cause the tissue support portion to support levator tissue.Optionally the tissue support portion can be positioned below therectum, attached to the rectum, or attached to the external analsphincter.

Referring to FIG. 6, an embodiment of a method can include placing theimplant, e.g., the tissue support portion or a distal end of anextension portion, into contact with supportive tissue selected from:sacrotuberous ligament, periostium of the pubic bone (not shown in FIG.6), pubourethral ligament (also not shown, but connects urethra to pubicbone), arcus tendineus (not shown), anococcygeal body ligament (notspecifically shown), sacrospinous ligament (not shown in FIG. 6), aregion of the ischial spine, or ischial tuberosity. Alternately oradditionally, the tissue support portion or an extension portion can beattached to periostium of the pubic bone in a region of the ischialtuberosity. Alternately or additionally, a tissue support portion orextension portion can be extended through a tissue path between levatorani muscle and obturator internus muscle and attached at the arcustendineus (white line), at the obturator membrane, or extend through theobturator foramen to an external incision at the inner thigh.

In general for a fecal incontinence sling and other pelvic floor andlevator ani muscle repairs, anchoring points for a tissue fastener suchas a self-fixating tip or a bone anchor could include sacrotuberousligament laterally or the periostium of the pubic bone—specifically bythe ischial tuberosity. Additionally, a bone anchor could be placed atthe ischial tuberosity to attach the sling internally at the pelvicregion. The sling can pass under the external anal sphincter and beattached laterally at each side (e.g., at the ischial tuberosity).According to one specific embodiment, the sling could be placed usingself-fixating tips. In addition, the sling and self-fixating tips couldbe placed between the levator ani muscle and the obturator internusmuscle, attaching the fascial white line or “arcus tendineus.”Optionally and preferably the sling could be placed directly over thesuperficial transverse perineal muscle, adding the foundational supportof the pelvic floor.

In this embodiment, while wishing to not be bound by theory, it isbelieved that the sling will not only function to restore the analrectal angle but will also or alternately provide a backstop for thelevator muscles. This will allow the anus more support for closure andmaintenance of continence. Restoring the anchoring point of the levatorani muscles allows them to contract more efficiently to close off theanal canal.

Alternately or in addition, the sling can be attached to thepuborurethral ligament, which may restore the rectal angle. Curing fecalincontinence in this manner is at least in part due to restoring theleverage points for the levator plate and longitudinal muscle of theanus, in addition to any improvement due to restoring the anal rectalangle.

Yet another possible placement for a tissue fastener can be the sacrum,e.g., using a bone anchor, or at the sacrospinous ligament oranococcygeal body ligament, by attaching a tissue fastener.

According to still further embodiments, an extension portion of animplant can pass through a tissue path in the pelvic region to anexternal incision, such as: through a tissue path that extends to anexternal incision in at the abdomen; through a tissue path that extendsabove the pubic bone to a suprapubic incision; through a tissue paththat extends through an obturator foramen and to an external incision atthe inner thigh; through a tissue path that extends laterally through aregion of the coccyx to an external incision adjacent to the coccyx; orthrough a tissue path that extends to an external incision at aperirectal or perianal region.

As is apparent from the present description, an implant can be installedby any one or combination of incisions that can result in direct accessto levator or coccygeus tissue, or access to a tissue path that extendsfrom the external incision to levator or coccygeus tissue. Examples area perirectal incision that allows open access to tissue of the pelvicfloor; a small external perirectal incision that can allow a tissue pathto extend from the external perirectal incision to tissue of the pelvicfloor, a small external incision in a region of the coccyx that canallow a tissue path to extend from the external incision to tissue ofthe pelvic floor; a suprapubic incision that involves a small or largeexternal incision at the suprapubic position; a transobturator approachwhereby an extension portion of an implant can be placed through atissue path leading from an external incision at the inner thigh,through an obturator, and to an implant located to support tissue of thepelvic floor; the use of a Kraske incision, e.g., an incision under therectum; a “modified Kraske” incision; a perineal incision; and a vaginalincision. Certain useful methods can involve reduced need for externalincisions based on the use of internal tissue fasteners such asself-fixating tips, to fasten the implant to internal tissue of thepelvic region and eliminate the need for exit points of extensionportions.

According to one exemplary tissue path, the transobturator tissue path,extension portion of an implant can extend from a tissue support portionat the levator tissue, through a superior aspect of the obturatorforeman. Passage through the superior aspect—very top of the obturatorforamen—may result in support such as would be provided by thepubococcygeal ligament, and tightening of the levator hiatus, which canrepair the perineal body and restore the anorectal angle. Generally,transobturator tissue approaches are described at pending applicationSer. No. 11/347,047 “Transobturator Methods for Installing Sling toTreat Incontinence, and Related Devices,” filed Feb. 3, 2006, and at USpublication 2005/0143618 (Ser. No. 11/064,875) filed Feb. 24, 2005, theentireties of these being incorporated herein by reference.

An example of a suprapubic approach (external incision approach) isillustrated at FIG. 7. Referring to FIG. 7, relevant anatomy includescoccyx 240, white line 242, rectum 244, vagina 246, urethra 248, andpubic bone 250. Insertion tool 252 includes a needle connected toimplant 254. A portion (not shown) of implant 254 is located to contactlevator tissue and support levator tissue, and a portion (illustrated)such as an extension portion, optionally including a connector forengaging the end of the needle, connects to the needle and is pulledthrough a tissue path leading from the levator to an external incisionin the suprapubic region.

In general, an incision that is in a region of the perineum can be anincision at that location, e.g., between a vagina and an anus in afemale. An incision in the perirectal region can be, for example, within1 to 4 centimeters of the anus.

An example of a “modified” Kraske incision (260) (modified to a verticalorientation) is illustrated at FIG. 8. An example of a perirectal orperianal incision (262) is illustrated at FIG. 8A. Another example of aperirectal or perianal incision (264) is illustrated at FIG. 8B. Anexample of a perineal incision (266) is illustrated at FIG. 8A. All ofthese types of incision allow access to pelvic floor tissue forimplantation of one or two portions of a sling in contact with levatortissue (illustrated in shadow).

Examples of various tissue paths, relevant anatomy, implant materials,features of implants (e.g., connectors, tensioning devices), insertiontools, are described, for example, in U.S. Publication Nos. 2002/0161382(Ser. No. 10/106,086) filed Mar. 25, 2002; 2005/0250977 (Ser. No.10/840,646) filed May 7, 2004; and 2005/0245787 (Ser. No. 10/834,943)filed Apr. 30, 2004; 2005/0143618 (Ser. No. 11/064,875) filed Feb. 24,2005; and U.S. Pat. No. 6,971,986 (Ser. No. 10/280,341) filed Oct. 25,2002; U.S. Pat. No. 6,802,807 (Ser. No. 09/917,445) filed Jul. 27, 2001;U.S. Pat. No. 6,612,977 (Ser. No. 09/917,443) filed Jul. 27, 2001; U.S.Pat. No. 6,911,003 (Ser. No. 10/377,101) filed Mar. 3, 2003; U.S. Pat.No. 7,070,556 (Ser. No. 10/306,179) filed Nov. 27, 2002,PCT/US2007/004015 “Surgical Articles and Methods for Treating PelvicConditions,” filed Feb. 16, 2007; PCT/US2007/014120 “Surgical Implants,Tools, and Methods for Treating Pelvic Conditions, filed Jun. 15, 2007;the entireties of each of these being incorporated herein by reference.

Example Levator Distention Repair

1. Blunt Dissection

-   -   a. Make a transverse incision, approximately 2 cm inferior to        the anus and 3 cm long, similar to a Krasky incision,        -   i. There is an option here of dissecting through or            superficial to the anococcygeal ligament. Dissection            superficial to the ligament may provide a backstop for the            rectum without putting it in tension or risking erosion.            However, for severe fecal incontinence, or if greater            tensioning was required, the ligament could be dissected as            well and the mesh placed behind it.    -   b. Insert a finger into the incision and tunnel toward the        ischial spine on the patient left side. Use blunt dissection        with your finger to open the space to the spine. The finger will        lie between the levator muscle (medial) and fatty tissue        (lateral).    -   c. Make a sweeping motion with your finger, creating a space        between the fat and muscle, between the ischial spine and the        posterior edge of the obturator foramen on the inferior pubic        ramus.    -   d. Repeat B & C on the patient right side.

2. Mesh Placement with Needle

-   -   a. Insert a needle through the anchor on one of the mesh arms.    -   b. Placing your finger on the inferior pubic ramus near the        obturator foramen, run the needle along your finger until the        end with the anchor pushes into the tissue, into the obturator        internus muscle.    -   c. Remove the needle by pulling out of the incision. Give the        mesh a tug to ensure the anchor has caught tissue. Insert the        needle into the anchor on the other mesh arm.    -   d. Place your finger on the ischial spine, and run the needle        along your finger until the end with the anchor pushes into the        tissue, near the ischial spine in the levator muscle.    -   e. Remove the needle.    -   f. Sweep along the mesh, smoothing the area between the anchors        and sweeping the tail end beneath the rectum.    -   g. Repeat steps A-F on the contralateral side.

3. Close incision with suture.

-   -   a. lithe ligament was dissected, rejoin the ends of the ligament        over the mesh before closing the incision.

The invention claimed is:
 1. A pelvic implant for supporting levatortissue, the implant comprising a first tissue support portion boundedby: an anterior side capable of extending on a first side of a patientfrom an anterior region of the pelvic region to a region of mediallevator tissue on the first side of the patient, the anterior regionselected from a region of the obturator foramen, a region of the arcustendineus, and a region of puborectalis muscle, a posterior side capableof extending on the first side of the patient from a posterior region ofthe pelvic region to a region of medial levator tissue, the posteriorregion selected from a region of the ischial spine, an ischialtuberosity, a sacrospinous ligament, a sacrotuberous ligament, and asacrum, a lateral end capable of extending from the anterior region tothe posterior region on the first side of the patient, and a medial endcapable of being located at a medial position below levator tissueselected from a rectum, an external anal sphincter, a perineal body, andan anococygeal body, when the first tissue support portion is located ata region of levator tissue and inferior to the levator tissue on thefirst side of the patient; and a second tissue support portion boundedby: an anterior side capable of extending on a second side of thepatient from an anterior region of the pelvic region to a region ofmedial levator tissue, the anterior region selected from a region of theobturator foramen, a region of the arcus tendineus, and a region ofpuborectalis muscle, a posterior side capable of extending on the secondside of the anent from a posterior region of the pelvic region to aregion of medial levator tissue, the posterior region selected from aregion of the ischial spine, an ischial tuberosity, a sacrospinousligament, a sacrotuberous ligament, and a sacrum, a lateral end capableof extending from the anterior region to the posterior region on thesecond side of the patient, and a medial end capable of being located ata medial position below levator tissue selected from a rectum, anexternal anal sphincter, a perineal body, and an anococygeal body, whenthe second tissue support portion is located at a region of levatortissue inferior to the levator tissue, on the second side of thepatient, wherein the first and second tissue support portions have awidth of the medial end less than a width of the lateral end.
 2. Theimplant of claim 1 wherein the first tissue support portion and thesecond tissue support portion each independently have a shapesubstantially of a figure selected from a symmetric trapezoid, and anon-symmetric trapezoid.
 3. The implant of claim 1 comprising one or twoextension portions located at corners of the first tissue supportportion along the lateral end.
 4. The implant of claim 3 comprising atissue fastener located at a lateral end of the one or two extensionportions.
 5. The implant of claim 3 wherein the extension portions areabout 1 to about 1.5 centimeters wide.
 6. The implant of claim 1comprising a tissue fastener located at a corner of the first tissuesupport portion.
 7. The implant of claim 1 comprising two tissuefasteners located at each corner of the first and second tissue supportportions.
 8. The implant of claim 1 wherein the medial end of the firsttissue support portion is attached to the medial end of the secondtissue support portion.
 9. The implant of claim 1 comprising one or twoextension portions located at corners of the first and second tissuesupport portions along the lateral ends.
 10. The implant of claim 1wherein a length of the implant is about 14 to about 18 centimeters. 11.The implant of claim 1 wherein the width of the lateral end of the firsttissue support portion is about 4 to about 5 centimeters.
 12. Theimplant of claim 1 wherein the width of the medial ends of the tissuesupport portions is about 2 to about 3 centimeters.
 13. The implant ofclaim 1 having a length in a range from about 14 to about 18centimeters.
 14. The implant of claim 1 wherein the width of the lateralend of the second tissue support portion is about 4 to about 5centimeters.
 15. The implant of claim 1, having a width of the medialend of the second tissue support portion is in a range from about 2 toabout 3 centimeters.
 16. The implant of claim 1 wherein the first tissuesupport portion and the second tissue support portion each have a shapesubstantially of a figure selected from a symmetric trapezoid and anon-symmetric trapezoid.
 17. The implant of claim 1 wherein the firsttissue support portion has a trapezoid shape and the second tissuesupport portion has a trapezoid shape.
 18. The implant of claim 1wherein the first tissue support portion has a symmetric trapezoid shapeand the second tissue support portion has a symmetric trapezoid shape.19. The implant of claim 1 wherein the widths of the lateral ends of thefirst and second tissue support portions are about 3 to about 7centimeters and the widths of the medial ends of the first and secondtissue support portions are about 2 to about 3 centimeters.
 20. Theimplant of claim 1, comprising one piece comprising the first tissuesupport portion and the second tissue support portion.